Precigen Names Rutul R. Shah Chief Operating Officer Effective October 1
GERMANTOWN, Md., Sept. 21, 2022 /PRNewswire/ -- Precigen, Inc. (NASDAQ:PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the